Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs
Warp Sciences, a startup co-founded by former OpenAI CPO Kevin Weil, Meta VP Manohar Paluri, and other industry leaders, raised $215 million in Series A funding led by Lightspeed Ventures. The company operates as a chemistry contract research organisation, combining AI models, robotics and chemists to accelerate drug discovery and molecular testing for pharmaceutical and biotech clients. The funding round included participation from Premji Invest, Mayfield, IVP and other VCs, plus backing from notable angel investors including Coinbase CEO Brian Armstrong and Databricks co-founder Ion Stoica.
Key points
- $215M Series A funding led by Lightspeed Ventures
- AI and robotics applied to chemistry research and drug discovery
- Co-founders from OpenAI, Meta and healthcare leadership
- Operates as contract research organisation for pharmaceutical clients
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Analytics India Magazine did the reporting; read the original for the full story.
Read the full story at Analytics India Magazine
